Skip to content

Bunge Global stock

BGNYSE

Bunge Global S.A., Consumer DefensiveISIN CH1300646267

$99.98▼ $0.30 (−0.3%)Closing price of 12 Nov 2026

43Score 43 out of 100, Weak

Turn on early warning

Price and trend

43 / 100

Price history

+3.8% in one year

The chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.

Long-term trend

Below the 200-day line: the price is 14% below it.

Trend change

Since September 2026 the 50-day line has been below the 200-day line; the trend has turned down.

Momentum

Normal: the price is neither overheated nor sold off (RSI 42).

Distance to the high

The price is 24% below its 52-week high. Largest decline in 20 years: 77% (January 2008 to October 2008).

Chart figures for advanced users
SMA 50$107.60
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$116.54
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)42
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDabove the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$88.55
The lowest closing price of the last twelve months.
Resistance$131.41
The highest closing price of the last twelve months.
Market cap
$19.27B
Div. yield
2.83%
12 months
16.8
on reported earnings of the last twelve months
9.2
on earnings for the next twelve months ($10.90 per share)
Fair value
$70.58

Snapshot

Computed from the data by fixed rules, no AI

  • Bunge Global S.A. belongs to the Agricultural Farm Products industry (United States) and, with a market value of $19.21B, is number 5 of 24 companies in its industry on MEQIRI.
  • In fiscal 2025 it reported revenue of $70.33B (up 32.4% year on year) and earnings of $816M (down 28.2%).
  • For fiscal 2026, analysts expect on average revenue of $93.65B (up 33.2%) and adjusted earnings per share of $9.42 (up 27.7%).
Show more
  • MEQIRI Score 43 out of 100 (Weak): rank 271 of 295 in Consumer Defensive, median 62.
  • The P/E is 16.7 (Agricultural Farm Products median 16.6, own median of recent years 9.6).
  • Our model puts fair value at $70.58, with the price 42% above it.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

  • Reliable dividendNo dividend cut for 24 years.
  • Analysts expect strong earnings growthUp 15.4% a year through 2027 (estimates from 4 analysts).

Weaknesses

  • Negative free cash flowFree cash flow −$2.66B over the last 12 months.Fundamentals 43
  • DilutionShare count up 17% since 2020.Capital allocation 32
  • Interest barely coveredOperating profit covers interest only 2.8 times.Stability 59
43/ 100
MEQIRI Score
Weak

The score is held back by capital allocation and profitability.

Daily figure as of 12 Nov 2026

How the score is calculated

Score overview

Fundamental quality fluctuates.

Profit consistency90% of years
Cash conversion (free cash flow to earnings, 12 months)−229%
ROIC (12 months)5.6%
Positive free cash flow20% of years
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Crash risk high

How well MEQIRI warns

One of the 30% with the highest crash risk among stocks ranked 101 to 1,000.

From 2016 to 2025, 23 in 100 such stocks fell 30% or more within a year, against a group average of 15 in 100.

What drives the risk

  • weak fundamentals

Valuation

Valuation signal

Modestly overvalued
Price
$100.28
Fair value
$70.58
Gap to fair value
+42%

Closing price of 11 Nov 2026, used by the daily score.

In our model the price counts as cheap below $50.41 and expensive above $117.63 (uncertainty high, one part of the fair value is more than twice the other).

The two parts of the fair value come to $41.74 (cash-flow model) and $99.41 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is above both.

Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $66.77, at 7.8% it would be $76.30.

Valuation metrics

1.28
11.9
Fair value (model)
$70.58
Earnings part $99.41 (earnings per share $5.97 × 16.6)

Half from the cash-flow model, half from earnings times the industry P/E (16.6).

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

20 years

In the twelve months to 30 Sep 2026, revenue rose 55.5% on the twelve months before. Revenue has grown solidly since 2006, at about 5% per year.

Margins

20 years
  • Gross margin
  • Operating margin
  • Net margin

In fiscal 2025: gross 5%, operating 2%, net 1%.

Debt & balance sheet

latest quarter
1.02
2.8x
1.5
Cash & equivalents
$524M

Debt is elevated. Keep an eye on the interest burden and refinancing.

Earnings

Next earnings
3 Feb 2027in 83 days
Last reported
29 Oct 2026EPS reported $2.56 (expected $2.41)above expectations

Analyst estimates

Earnings estimates have barely changed since 15 Oct 2026.

Fiscal 20264 analysts
Earnings per share
$9.42−0.2%
Revenue
$93.65B+1.3%
Fiscal 20275 analysts
Earnings per share
$11.13+0.4%
Revenue
$96.98B+2.0%

MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.

Company outlook mixed

Share price after the results: −4.1%

Bunge maintains its 2026 adjusted EPS outlook of $9.25 to $9.75, but slightly lowers the outlook for Soybean Processing and Tropical Oils, raises expected interest expense and capex, while Grain Merchandising is expected to be higher.

Supporting passage from the call, verbatim
“Taking into account Q3 results, the current margin and macro environment and forward curves, we continue to expect full year 2026 adjusted EPS in the range of $9.25 to $9.75.”

The outlook is not part of the score and not a recommendation to buy or sell.

From the earnings call on 29 Oct 2026 (fiscal Q3 2026), read by AI.

Insiders

Open-market purchases and sales by executives, board members and major holders

All insider purchases

One insider bought on the open market in the last 6 months, $689,050 in total.

  • Mahoney ChristopherPurchase

    4 Aug 2026, Board

    Shares
    1,500
    Price
    $107.60
    Value
    $161,400
  • Mahoney ChristopherPurchase

    31 Jul 2026, Board

    Shares
    5,000
    Price
    $105.53
    Value
    $527,650

Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.

What happened at Bunge Global

The key events of the last six months from our own data. A click takes you to the matching card.

Sector comparison

295 rated companies in Consumer Defensive

Rank 271 of 295
271/ 295
This company
43
Sector median
62

Categories against the sector median

ProfitabilityMedian of 295 companies28 (median 54)26 below the median
GrowthMedian of 295 companies49 (median 50)1 below the median
FundamentalsMedian of 295 companies43 (median 79)36 below the median
ValuationMedian of 290 companies with a value59 (median 65)6 below the median
StabilityMedian of 295 companies59 (median 68)9 below the median
Capital allocationMedian of 295 companies32 (median 62)30 below the median
Technical analysisMedian of 295 companies43 (median 65)22 below the median
MomentumMedian of 295 companies39 (median 60)21 below the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in Agricultural Farm Products

The next larger and next smaller companies by market value

All 24 Agricultural Farm Products stocks

ETFs that hold Bunge Global

Held by 105 ETFs on Xetra. Shown per index: the ETF with the largest weight.

Show 5 more

Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).

Data status and sources

Score
Daily value of 12 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Weak, published since 7 Nov 2026 (in the score history since 18 Sep 2026)
  • Valuation signal Fairly valued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy